- Market Capitalization, $K 64,176
- Shares Outstanding, K 12,510
- Annual Sales, $ 7,200 K
- Annual Income, $ -6,470 K
- 60-Month Beta -0.68
- Price/Sales 8.05
- Price/Cash Flow N/A
- Price/Book 6.29
|Period||Period Low||Period High||Performance|
| || |
+0.90 (+21.28%)since 08/24/21
| || |
+1.06 (+26.04%)since 06/24/21
| || |
-1.51 (-22.74%)since 09/24/20
Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods diagnostic-guided therapy (DGT), designed to alleviate Irritable Bowel Syndrome...
-- Revenues increase 7.6% for fiscal 2021 vs fiscal 2020.
Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica's first patent pertaining to a revolutionary new treatment option for patients...
-- Digital Health Advertising and Social Media Campaigns launching alongside new site
an investor conference themed around investor education and advocacy begins next week, July 13 - 15, 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period...
Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribution and marketing of Biomerica's new and proprietary...
-- IBS is one of the most important gastrointestinal disorders in Mexico, with a prevalence of around 16% (approximately 20 million patients)
Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor conferences: the Truist Life Sciences Series and LD...
The Summer Solstice - Best Ideas from the Buy-Side will take place on June 1-4, 2021, where 35 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor...
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, LODE, ONTX, PLTR, and BMRA.